Tvardi Therapeutics (TVRD) Institutional Ownership $23.66 +0.54 (+2.34%) As of 03:02 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tvardi Therapeutics (NASDAQ:TVRD)CurrentInstitutional OwnershipPercentage44.66%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.62MNumber ofInstitutional Sellers(last 12 months)0 Get TVRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Tvardi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Tvardi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2025Geode Capital Management LLC112,138$2.62M0.0%N/A1.198% (Data available from 1/1/2016 forward) TVRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TVRD shares? During the previous two years, the following institutional investors and hedge funds held shares of Tvardi Therapeutics shares: Geode Capital Management LLC ($2.62M).Learn more on Tvardi Therapeutics' institutional investors. What percentage of Tvardi Therapeutics' stock is owned by institutional investors? 44.66% of Tvardi Therapeutics' stock is owned by institutional investors. Learn more on TVRD's institutional investor holdings. Which institutional investors have been buying Tvardi Therapeutics' stock? The following institutional investors have purchased Tvardi Therapeutics' stock in the last 24 months: Geode Capital Management LLC ($112.14K). How much institutional buying is happening at Tvardi Therapeutics? Institutional investors have bought a total of 112,138 shares in the last 24 months. This purchase volume represents approximately $2.62M in transactions. Related Companies Akebia Therapeutics Major Shareholders Arcus Biosciences Major Shareholders Anavex Life Sciences Major Shareholders Collegium Pharmaceutical Major Shareholders Enliven Therapeutics Major Shareholders Mineralys Therapeutics Major Shareholders Sana Biotechnology Major Shareholders Immunome Major Shareholders Urogen Pharma Major Shareholders Zymeworks Major Shareholders This page (NASDAQ:TVRD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tvardi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tvardi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVRD Stock Alerts